Ultragenyx Pharmaceutical Inc.

États‑Unis d’Amérique


 
Quantité totale PI 175
Rang # Quantité totale PI 7 415
Note d'activité PI 3/5.0    136
Rang # Activité PI 5 054
Symbole boursier
ISIN US90400D1081
Capitalisation 4,600M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

50 44
19 7
44 5
6
 
Dernier brevet 2025 - Methods of producing cdkl5 prote...
Premier brevet 2011 - Method and formulations for trea...
Dernière marque 2025 - OZYVYO
Première marque 2013 - ULTRAGENYX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical preparations for the treatment of bone, genetic, joint, metabolic, musculoskeletal...
P/S Pharmaceutical, scientific, and medical research and development in the field of one, genetic, jo...
P/S Providing medical services in the field of bone, genetic, joint, metabolic, musculoskeletal, oste...
2024 P/S Pharmaceutical, scientific, and medical research and development in the field of bone, genetic, j...
P/S Providing medical services in the field of genetic, central nervous system, and lysosomal storage...
P/S Pharmaceutical preparations for the treatment of genetic, central nervous system, and lysosomal s...
P/S Pharmaceutical, scientific, and medical research and development in the field of genetic, central...
Invention Methods of producing cdkl5 proteins and uses of the same. The present disclosure provides novel m...
Invention Compositions and methods for treating conditions associated with bsep deficiency. This applicatio...
Invention Compositions and methods for reducing host cell proteins in recombinant adeno-associated virus pr...
Invention Formulations comprising recombinant aav and methods of administering the same. e.g.e.g., rare gen...
Invention Engineered producer cell lines and methods of making and using the same. This application relate...
Invention Human fgf23-binding antibodies with improved affinity and efficacy. The disclosure provides impro...
Invention Methods of heat inactivation of adenovirus. The present disclosure generally relates to methods ...
Invention Crystalline forms of sialic acid derivatives and methods for their use. The present disclosure re...
2023 Invention Method of producing soluble microdystrophin protein and uses of the same. The present disclosure ...
Invention Sialylated glycoprotein compositions and uses thereof. The present application relates to sialyl...
Invention Method for determination of double-stranded rna impurity. e.ge.g., a sample solution that compris...
P/S Pharmaceutical preparations and substances for the treatment of metabolic and rare diseases and ...
P/S Pharmaceutical preparations and substances for the treatment of metabolic and rare diseases and d...
Invention Novel anion-exchange chromatography methods for separation of empty from full recombinant adeno-a...
Invention Effective and efficient control of serum phosphate for optimal bone formation. The present inven...
Invention Creatine prodrugs, compositions and methods of use thereof. The present disclosure provides crea...
P/S Printed publications, namely, books, brochures, white papers, informational pamphlets, informatio...
P/S Compiling of data for research purposes in the field of rare diseases and disorders; medical and ...
P/S Organizing business networking events in the field of rare diseases and disorders; organizing bus...
P/S Education and training services, namely, seminars, classes, workshops, and providing non-download...
Invention Modified batch aav production systems and methods. e.g.e.g., intensified perfusion) for increasin...
Invention Modified batch aav production systems and methods. This application provides modified batch syste...
P/S Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and ...
Invention Certain dux4 inhibitors and methods of use thereof. This application relates to double-stranded s...
Invention Solid compositions of triglycerides and uses thereof. The present invention includes solid compo...
P/S Chemical, biological, and biochemical products for use in gene delivery technology, namely, nucle...
P/S printed publications, namely, books, brochures, informational pamphlets, informational cards, and...
P/S Research and development in the field of gene therapy manufacturing technology; biomedical and sc...
P/S Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central ne...
P/S providing medical services, namely, gene therapy design and delivery services being gene therapy ...
P/S Licensing of intellectual property
2022 P/S Chemical, biological, and biochemical preparations for use in gene delivery technology, namely, n...
Invention Engineered cell lines for increased production of recombinant adeno-associated virus (raav). Thi...
Invention Engineered cell lines for increased production of recombinant adeno-associated virus (raav). This...
Invention Methods of using anti-sclerostin antibodies in treatment of osteogenesis imperfecta. Disclosed a...
Invention Methods of using anti-sclerostin antibodies in treatment of osteogenesis imperfecta. Disclosed ar...
Invention Methods and compositions for the treatment of amyloidosis. Methods and compositions for the trea...
Invention Recombinant aav formulations. This present disclosure provides pharmaceutical compositions for d...
Invention Recombinant aav formulations. This present disclosure provides pharmaceutical compositions for de...
Invention Anion-exchange chromatography methods for purification of recombinant adeno-associated viruses. ...
Invention Anion-exchange chromatography methods for purification of recombinant adeno-associated viruses. P...
Invention Compositions and methods for treating a muscular dystrophy. The present disclosure provides nove...
Invention Compositions and methods for treating a muscular dystrophy. The present disclosure provides novel...
Invention Therapeutics for glycogen storage disease type iii. This invention provides a range of translata...
Invention Creatine prodrugs, compositions and methods of use thereof. The present disclosure provides creat...
P/S Providing medical services, namely, gene therapy design and delivery services being gene therapy ...
2021 Invention Methods for treating tumor-induced osteomalacia. The present invention provides compositions and ...
Invention Sialylated glycoprotein compositons and uses thereof. The present application relates to sialyla...
Invention Dux4 inhibitors and methods of use thereof. This application relates to double-stranded small in...
Invention Dux4 inhibitors and methods of use thereof. This application relates to double-stranded small int...
P/S Clinical diagnostic reagents for medical and veterinary use, including in vitro diagnostic reage...
Invention Methods of heat inactivation of adenovirus. The present disclosure generally relates to methods o...
Invention Gene therapy for treating propionic acidemia. This present disclosure provides recombinant adeno...
Invention Gene therapy for treating propionic acidemia. This present disclosure provides recombinant adeno-...
Invention Compositions and methods for reducing reverse packaging of cap and rep sequences in recombinant a...
Invention Methods for enhancing recombinant adeno-associated virus yield. The invention provides methods f...
Invention Methods for enhancing recombinant adeno-associated virus yield. The invention provides methods fo...
Invention Gene therapy for treating cdkl5 deficiency disorder. This present disclosure provides adeno-asso...
Invention Chaotropic agents for reducing formation of double-stranded rna. The present disclosure provides...
2020 P/S pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage dis...
Invention Methods for improved therapeutic use of recombinant aav. Provided herein are methods for managin...
P/S Compiling data into computer databases for research purposes in the field of rare diseases and d...
P/S Compiling data into computer databases for research purposes in the field of rare diseases and di...
Invention Compositions and methods for treatment of hemochromatosis. This application provides polynucleot...
P/S Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage dis...
Invention Gene therapy constructs for treating wilson disease. This application relates to adeno-associate...
2019 Invention Methods and compositions for treating glycogen storage diseases. This invention provides a varie...
P/S Providing medical research and scientific research information in the field of hypophosphatemia; ...
P/S Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage di...
P/S Downloadable computer software for use in inputting, gathering, monitoring, sharing, and analyzin...
P/S providing medical research and scientific research information in the field of hypophosphatemia; ...